Innovation in Plant Biotechnology

Global Public Sector Product Pipeline

The Public Sector Product Pipeline includes information on active R&D projects globally involving plant biotechnology in the public sector. The majority of these projects are the result of public-private partnerships, and include research that has moved beyond proof of concept and at least into the confined field trial stage.

Note that all information included in the database is based on publicly-available information; individual research organizations should be contacted for more specific detail on these research projects. As such, every effort is made to update the database, but entries may not be fully inclusive of all ongoing programs.

View Public Sector Product Pipeline

To bring new plant biotechnology to market it takes roughly 136 million dollars and 13 years of research and development.

The cost and time involved in the discovery, development and authorization of a new plant biotechnology derived trait.

An inventory of traits in the private sector pipeline.

GIC Submission of Information on Risk Assessment

Mar 18, 2019 - Document
Download

This document presents the GIC’s views on risk assessment and risk management issues related to gene drives and living modified fish.
Final GIC Submission on Synthetic Biology – February 2019

Feb 11, 2019 - Document
Download

The Global Industry Coalition (GIC) is pleased to make the following submission of information on synthetic biology in response to the request of the Executive Secretary for “information and supporting documentation” on four topics from decision XIV/19 of the Conference of the Parties to the Convention on Biological Diversity (CBD). In this submission, the GIC provides an in-depth analysis of the four topics (A – D) listed in the decision and notification SCBD/CP/DC/MA/MW/87791. This submission is supported by recent peer-reviewed publications and information from relevant sources as noted.
CropLife Statement on European Patent Office Decision on the Patentability of Plants Obtained by Essentially Biological Processes (Case T 1063/18)

Dec 14, 2018 - News Item
Download

CropLife welcomes the decision of the European Patent Office (EPO) in case T1063/18 declaring Rule 28(2) as not applicable because it is in conflict with Art 53b) of the European Patent Convention. Rule 28(2) in the Implementing Regulations of the European Patent Convention excludes from patentability of plants exclusively obtained by means of an essentially biological process. CropLife also notes that the Board of Appeal also decided to remit the case to a first instance for further examination of remaining patentability requirements.

Share: